Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs200855822 | chr15:30782220 | GT/G | 0 | 176 | 25.92 | 20.37 | 3.17 | KM Plot |
PCPG | rs200900777 | chr8:126209289 | TG/T | 2.95E-5 | 178 | 25.35 | 28.3 | 4.17 | KM Plot |
PCPG | rs200939653 | chr16:89821620 | ATT/A | 0.000244 | 173 | 25.87 | 20.13 | 36.37 | KM Plot |
PCPG | rs200987851 | chr2:118563433 | G/A | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs200993858 | chr7:158874354 | C/T | 0 | 176 | 25.28 | 41.8 | 3.17 | KM Plot |
PCPG | rs201018238 | chr10:29834962 | T/TA | 5.57E-11 | 175 | 25.6 | 22.05 | 10.3 | KM Plot |
PCPG | rs201064923 | chr7:38763161 | C/CA | 1.02E-7 | 178 | 25.87 | 19.88 | 19.87 | KM Plot |
PCPG | rs201230143 | chr12:56738816 | GC/G | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs201273995 | chr16:71802662 | C/CA | 0.000172 | 172 | 24.7 | 29.43 | 6.58 | KM Plot |
PCPG | rs2013260 | chr17:65796533 | C/T | 0.000472 | 176 | 24.5 | 36 | 8.22 | KM Plot |
PCPG | rs201333872 | chr13:114153217 | GT/G | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs201401518 | chr2:118566013 | G/T | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs201787946 | chr13:114170878 | CT/C | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2018682 | chr22:21317432 | A/G | 0.000411 | 178 | 24.1 | 28.47 | 22.33 | KM Plot |
PCPG | rs201967097 | chr2:242554304 | CAAAACAAAAACA/C | 4.16E-5 | 177 | 25.87 | 27.27 | 20.2 | KM Plot |